ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients
Approximately five months after launch, the inclusion of neffy on these three…
ANI Pharmaceuticals to Present at Raymond James Institutional Investors and Leerink Partners Global Healthcare Conferences in March
February 19, 2025 16:30 ET | Source: ANI Pharmaceuticals, Inc. PRINCETON, N.J.,…
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
TAIPEI, Feb. 17, 2025 /PRNewswire/ -- TAHO Pharmaceuticals announces positive preliminary results…
Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders
New Patent expands patent estate covering Adial’s unique molecular genetic approach to…
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
February 06, 2025 16:35 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2025 17:42 ET | Source: ZENTALIS PHARMACEUTICALS SAN DIEGO, Feb.…
Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer
Results from DENALI Part 1b show an Objective Response Rate (ORR) of…
India-Sierra Leone Trade Ties: Strategic Partnership Opportunities in Pharmaceuticals, IT, and Industrial Development Explored
C. Krishna Shankar Appointed Honorary Trade Commissioner KOCHI, India, Jan. 28, 2025 /PRNewswire/…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…
X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor – licenced to Norgine for commercialisation in Europe.
LONDON, Jan. 24, 2025 /PRNewswire/ -- Following the licensing agreement with X4…